Divi's Laboratories Limited — Important, 18-04-2025: Arrangements for strategic, technical, manufacturing, or marketing tie up

Divi's Laboratories has signed a long-term manufacturing and supply agreement with a global pharmaceuticals company, focusing on the production of advanced intermediates. This international agreement is significant as it is expected to contribute meaningfully to revenue. No upfront payment is involved, and details regarding the customer are confidential. To support this new agreement, the company plans to invest ₹650 crores to ₹700 crores in capacity addition at its manufacturing facilities, which will be funded through internal accruals. This strategic move aims to enhance Divi's presence in custom synthesis and assures reliable supply for its customer, indicating a positive outlook for future growth and operational expansion.